{
  "paper_metadata": {
    "pmid": "35414854",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.30G>A",
      "protein_notation": "p.Val10Met",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Not specified",
        "phenotype": "Cardiac amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 55,
          "age_at_onset": 50,
          "age_at_diagnosis": 52,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Cardiac amyloidosis with heart failure",
          "evidence_sentence": "Patient P1 was diagnosed with cardiac amyloidosis at age 52."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 60,
          "age_at_onset": 58,
          "age_at_diagnosis": 59,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Cardiac amyloidosis with arrhythmias",
          "evidence_sentence": "Patient P2 presented with arrhythmias and was diagnosed at age 59."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 45,
          "age_at_onset": 40,
          "age_at_diagnosis": 42,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms at evaluation",
          "evidence_sentence": "Patient P3 was evaluated at age 45 but showed no symptoms."
        }
      ],
      "functional_data": {
        "summary": "The variant affects protein stability and amyloid fibril formation.",
        "assays": [
          "In vitro stability assays",
          "Fibril formation assays"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Not specified",
      "evidence_level": "Moderate",
      "source_location": "Table 1, Row 1",
      "additional_notes": "The variant is associated with a higher risk of developing cardiac amyloidosis.",
      "key_quotes": [
        "The V30M variant in TTR is known to have a significant impact on amyloid fibril formation."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Variants in the TTR gene associated with cardiac amyloidosis",
      "variants_extracted": 1
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text and tables."
  }
}